Medtronic Plc Stock Current Liabilities
| MDT Stock | USD 80.38 0.91 1.12% |
Medtronic PLC fundamentals help investors to digest information that contributes to Medtronic PLC's financial success or failures. It also enables traders to predict the movement of Medtronic Stock. The fundamental analysis module provides a way to measure Medtronic PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medtronic PLC stock.
Total Current Liabilities is likely to gain to about 10.9 B in 2024. Non Current Liabilities Total is likely to gain to about 36.5 B in 2024. Medtronic | Current Liabilities |
Medtronic PLC Company Current Liabilities Analysis
Medtronic PLC's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Medtronic PLC Current Liabilities | 7.17 B |
Most of Medtronic PLC's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medtronic PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Medtronic Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for Medtronic PLC is extremely important. It helps to project a fair market value of Medtronic Stock properly, considering its historical fundamentals such as Current Liabilities. Since Medtronic PLC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medtronic PLC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medtronic PLC's interrelated accounts and indicators.
Click cells to compare fundamentals
Medtronic Current Liabilities Historical Pattern
Today, most investors in Medtronic PLC Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Medtronic PLC's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Medtronic PLC current liabilities as a starting point in their analysis.
Medtronic PLC Current Liabilities |
| Timeline |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
Medtronic Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, Medtronic PLC has a Current Liabilities of 7.17 B. This is 308.89% higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current liabilities for all United States stocks is 9.33% higher than that of the company.
Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Medtronic PLC ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Medtronic PLC's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Medtronic PLC's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Medtronic Fundamentals
| Return On Equity | 0.0817 | ||||
| Return On Asset | 0.0423 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 125 B | ||||
| Shares Outstanding | 1.33 B | ||||
| Shares Owned By Insiders | 0.10 % | ||||
| Shares Owned By Institutions | 85.26 % | ||||
| Number Of Shares Shorted | 12.43 M | ||||
| Price To Earning | 20.44 X | ||||
| Price To Book | 2.05 X | ||||
| Price To Sales | 3.29 X | ||||
| Revenue | 31.23 B | ||||
| Gross Profit | 21.71 B | ||||
| EBITDA | 9.04 B | ||||
| Net Income | 3.78 B | ||||
| Cash And Equivalents | 1.54 B | ||||
| Cash Per Share | 8.59 X | ||||
| Total Debt | 24.36 B | ||||
| Debt To Equity | 0.51 % | ||||
| Current Ratio | 1.76 X | ||||
| Book Value Per Share | 38.95 X | ||||
| Cash Flow From Operations | 6.04 B | ||||
| Short Ratio | 1.96 X | ||||
| Earnings Per Share | 3.15 X | ||||
| Price To Earnings To Growth | 1.52 X | ||||
| Target Price | 94.0 | ||||
| Number Of Employees | 95 K | ||||
| Beta | 0.78 | ||||
| Market Capitalization | 107.94 B | ||||
| Total Asset | 90.95 B | ||||
| Retained Earnings | 30.39 B | ||||
| Working Capital | 12.62 B | ||||
| Current Asset | 23.6 B | ||||
| Current Liabilities | 7.17 B | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 2.18 % | ||||
| Net Asset | 90.95 B | ||||
| Last Dividend Paid | 2.75 |
About Medtronic PLC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medtronic PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtronic PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtronic PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Medtronic PLC Piotroski F Score and Medtronic PLC Altman Z Score analysis. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.Note that the Medtronic PLC information on this page should be used as a complementary analysis to other Medtronic PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Medtronic Stock analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is Medtronic PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medtronic PLC. If investors know Medtronic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.078 | Dividend Share 2.75 | Earnings Share 3.15 | Revenue Per Share 24.298 | Quarterly Revenue Growth 0.047 |
The market value of Medtronic PLC is measured differently than its book value, which is the value of Medtronic that is recorded on the company's balance sheet. Investors also form their own opinion of Medtronic PLC's value that differs from its market value or its book value, called intrinsic value, which is Medtronic PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medtronic PLC's market value can be influenced by many factors that don't directly affect Medtronic PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medtronic PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medtronic PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.